Transiently heritable fates and quorum sensing drive early IFN-I response dynamics

Single-cell analysis reveals TLR-induced macrophage heterogeneity and quorum sensing dictate population wide anti-inflammatory feedback in response to LPS

Understanding natural killer cell biology from a single cell perspective

Polymersomes as a potential platform for cancer immunotherapy

A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: the best micropillar geometry?

Artificial antigen-presenting cell topology dictates T cell activation

A universal microfluidic approach for integrated analysis of temporal homocellular and heterocellular signaling and migration dynamics

Microfluidic chip for precise trapping of single cells and temporal analysis of signaling dynamics

Hydrogels for single-cell microgel production: recent advances and applications

Guidelines for mouse and human DC generation

Revising immune cell coordination: origins and importance of single-cell variation

A microfluidic approach for probing heterogeneity in cytotoxic T-cells by cell pairing in hydrogel droplets

Single cell profiling reveals functional heterogeneity and serial killing in human peripheral and ex vivo-generated CD34+ progenitor-derived Natural Killer cells

Phenotypical diversification of early IFNα-producing human plasmacytoid dendritic cells using droplet-based microfluidics

Decoding the dynamics of multilayered stochastic antiviral IFN-I responses

An automated real-time microfluidic platform to probe single NK cell heterogeneity and cytotoxicity on-chip

Probing probing single-cell macrophage polarization and heterogeneity using thermo-reversible hydrogels in droplet-based microfluidics

Robust antigen-specific T cell activation within injectable 3D synthetic nanovaccine depots

Programmable bivalent peptide–DNA locks for pH-based control of antibody activity

A pipette-tip based method for seeding cells to droplet microfluidic platforms

Development of morphologically discrete PEG-PDLLA nanotubes for precision nanomedicine

Synthetic immune niches for cancer immunotherapy

Customizing poly(lactic-co-glycolic acid) particles for biomedical applications

Cytokine-functionalized synthetic dendritic cells for T cell targeted immunotherapies

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

Integrating immunology and microfluidics for single immune cell analysis

Injectable biomimetic hydrogels as tools for efficient T cell expansion and delivery

Controlling T-cell activation with synthetic dendritic cells using the multivalency effect

A membrane-anchored aptamer sensor for probing of IFNγ secretion by single cells

Affinity-based purification of polyisocyanopeptide bioconjugates

Circulating apoptotic microparticles in systemic lupus erythematosus patients drive the activation of dendritic cell subsets and prime neutrophils for NETosis

Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells

A comparative study of the T cell stimulatory and polarizing capacity of human primary blood dendritic cell subsets

Long-lasting multifunctional CD8+ T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated anti-tumor immune responses

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition

Dendritic cells as vaccines: key regulators of tolerance and immunity

Proteomics of human dendritic cell subsets reveals subset-specific surface markers and differential inflammasome function

CLEC12A-mediated antigen uptake and cross-presentation by human dendritic cell subsets efficiently boost tumor-reactive T cell responses

Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses

PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI

Selective expression of the MAPK phosphatase Dusp9/MKP-4 in mouse plasmacytoid dendritic cells and regulation of IFN-β production

Protamine-stabilized RNA as an ex-vivo stimulant of primary human dendritic cell subsets

Tumoricidal activity of human dendritic cells

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy

An electro-coalescence chip for effective emulsion breaking in droplet microfluidics

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells

One drop at a time: toward droplet microfluidics as a versatile tool for single-cell analysis

Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T-cells despite lower Ag uptake than myeloid dendritic cell subsets

CD56 marks human dendritic cell subsets with cytotoxic potential

Naturally circulating dendritic cells to vaccinate cancer patients

Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion

Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues

The C type lectin CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells

Harnessing human plasmacytoid dendritic cells as professional APCs

Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion

Deciphering the message broadcast by tumor infiltrating dendritic cells

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities

Potential applications for plasmacytoid dendritic cells in cancer immunotherapy

Interleukin-15-induced CD56+ myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and Herpes simplex virus-1

DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses

Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Cross-talk between human dendritic cell subsets influences expression of RNA sensors and inhibits picornavirus infection